Richard Hengel is an Infectious Disease physician affiliated with AID Atlanta. OpenAlex indexes 48 publications with 688 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
275 Collier Rd NW
Ste 450
Atlanta, GA 303091709
Telephone
404-355-3161Registry record last updated 14 Feb 2014.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20256 payments
- Merck Sharp & Dohme LLCProgram year20253 payments
- Aimmune Therapeutics, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor34.7%Tivicay65%Isentress19%Juluca16%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor22.6%Descovy59%Triumeq21%Emtricitabine20%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P-1958. Efficacy and Safety of Rezafungin, A Long-Acting Echinocandin
Open Forum Infectious Diseases
2026 - P-374. Long-term Effectiveness of Long-Acting Cabotegravir and Rilpivirine in an Infectious Disease Office-Based HIV Program
Open Forum Infectious Diseases
2026 - P-220. Real-World Effectiveness of Fecal Microbiota, live-jslm for the Prevention of Recurrent <i>Clostridioides difficile</i> Infection
Open Forum Infectious Diseases
2025 - P-1873. Telavancin Outcomes in Infections Treated with Outpatient Parenteral Antibiotic Therapy (OPAT)
Open Forum Infectious Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Juliette Morgan, MD
AID Atlanta
Amy Hostetter, MD
AID Atlanta
Dawn Smiley-Byrd, MD
AID Atlanta
Hector Malave, MD
AID Atlanta
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”